NS-398 promotes pancreatic cancer cell invasion by CD147 and MMP-2 via the activation of P38

Molecular Medicine Reports

Volumn 13, Issue 3, 2016, Pages 2208-2214

  Liu, Hua ^a   Xu, Xuan Fu ^a   Zhao, Yan ^a   Tang, Mao Chun ^a   Zhou, Ying Qun ^a   Gao, Feng Hou ^b  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cluster of differentiation 147; Invasion; Matrix metalloproteinase 2; NS 398; Pancreatic cancer cell

Indexed keywords

CD147 ANTIGEN; CYCLOOXYGENASE 2; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE P38; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; SMALL INTERFERING RNA; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PYRIDINE DERIVATIVE; SULFONAMIDE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD147; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; HUMANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NITROBENZENES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PYRIDINES; RNA, SMALL INTERFERING; SULFONAMIDES;

EID: 84958720893     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.4783     Document Type: Article

References (36)

1. Nentwich MF, Bockhorn M, König A, Izbicki JR and Cataldegirmen G: Surgery for advanced and metastatic pancreatic cancer-current state and trends. Anticancer Res 32: 1999-2002, 2012.
2. Fidler IJ: Origin and biology of cancer metastasis. Cytometry 10: 673-680, 1989.
3. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
4. Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell 144: 646-674, 2011.
5. Walsh N, O'Donovan N, Kennedy S, Henry M, Meleady P, Clynes M and Dowling P: Identification of pancreatic cancer invasion-related proteins by proteomic analysis. Proteome Sci 7: 3, 2009.
6. Ramer R, Weinzierl U, Schwind B, Brune K and Hinz B: Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells. Mol Pharmacol 64: 1189-1198, 2003.
7. Mollace V, Muscoli C, Masini E, Cuzzocrea S and Salvemini D: Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-252, 2005.
8. Pereira C, Sousa H, Silva J, Brandão C, Elgueta-Karstegl C, Farrell PJ, Medeiros R and Dinis-Ribeiro M: The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines. Mol Carcinog 53 (Suppl 1): E92-E95, 2014.
9. Wójcik M, Ramadori P, Blaschke M, Sultan S, Khan S, Malik IA, Naz N, Martius G, Ramadori G and Schultze FC: Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol 137: 217-233, 2012.
10. Young AL, Chalmers CR, Hawcroft G, Perry SL, Treanor D, Toogood GJ, Toogood GJ, Jones PF and Hull MA: Regional differences in prostaglandin E2 metabolism in human colorectal cancer liver metastases. BMC Cancer 13: 92, 2013.
11. Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K and Nakagawa K: Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16 (INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma. Oncol Lett 5: 903-910, 2013.
12. Yan WF, Sun PC, Nie CF and Wu G: Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: Evidence from a meta-analysis based on case-control studies. Tumour Biol 34: 3323-3330, 2013.
13. Hillion J, Smail SS, Di Cello F, Belton A, Shah SN, Huso T, Schuldenfrei A, Nelson DM, Cope L, Campbell N, et al: The HMGA1-COX-2 axis: A key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology 12: 372-379, 2012.
14. Okami J, Nakamori S, Hiraoka N, Tsujie M, Hayashi N, Yamamoto H, Fujiwara Y, Nagano H, Dono K, Umeshita K, et al: Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor. Clin Exp Metastasis 20: 577-584, 2003.
15. Duan DP, Dang XQ, Wang KZ, Wang YP, Zhang H and You WL: The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway. Oncol Rep 28: 1693-1700, 2012.
16. Youns M, Efferth T and Hoheisel JD: Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells. Eur J Pharmacol 650: 170-177, 2011.
17. Araki E, Forster C, Dubinsky JM, Ross ME and Iadecola C: Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 32: 2370-2375, 2001.
18. Kumar S, Boehm J and Lee JC: p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2: 717-726, 2003.
19. Chen X, Lin J, Kanekura T, Su J, Lin W, Xie H, Wu Y, Li J, Chen M and Chang J: A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness and metastatic activity of malignant melanoma. Cancer Res 66: 11323-11330, 2006.
20. Yoshida S, Ujiki M, Ding XZ, Pelham C, Talamonti MS, Bell RH Jr, Denham W and Adrian TE: Pancreatic stellate cells (PSCs) express cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs. Mol Cancer 4: 27, 2005.
21. Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS and Sweeney CJ: Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 21: 139-146, 2000.
22. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML and Sinicrope FA: Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 59: 4356-4362, 1999.
23. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT and Fahey TJ III: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999.
24. Wang X, Liang Y, Wang J and Wang M: Effect of NS-398, a cyclooxygenase-2 selective inhibitor, on the cytotoxicity of cytotoxic T lymphocytes to ovarian carcinoma cells. Tumour Biol 34: 1517-1522, 2013.
25. Honjo S, Osaki M, Ardyanto TD, Hiramatsu T, Maeta N and Ito H: COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines. DNA Cell Biol 24: 141-147, 2005.
26. Banu N, Buda A, Chell S, Elder D, Moorghen M, Paraskeva C, Qualtrough D and Pignatelli M: Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: Possibilities for combination therapy. Cell Prolif 40: 768-779, 2007.
27. Elder DJ, Halton DE, Playle LC and Paraskeva C: The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer 99: 323-327, 2002.
28. Yurchenko V, Constant S and Bukrinsky M: Dealing with the family: CD147 interactions with cyclophilins. Immunology 117: 301-309, 2006.
29. Yurchenko V, Constant S, Eisenmesser E and Bukrinsky M: Cyclophilin-CD147 interactions: A new target for anti-inflammatory therapeutics. Clin Exp Immunol 160: 305-317, 2010.
30. Gabison EE, Hoang-Xuan T, Mauviel A and Menashi S: EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87: 361-368, 2005.
31. Yang Y, Lu N, Zhou J, Chen ZN and Zhu P: Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 47: 1299-1310, 2008.
32. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P and Yan L: Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 4: 371-377, 2006.
33. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J and Kikuchi M: Emmprin (basigin/CD147): Matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56: 359-367, 2006.
34. Sun J and Hemler ME: Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 61: 2276-2281, 2001.
35. Kanekura T, Chen X and Kanzaki T: Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 99: 520-528, 2002.
36. Kolli-Bouhafs K, Boukhari A, Abusnina A, Velot E, Gies JP, Lugnier C and Rondé P: Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation. Invest New Drugs 30: 2121-2131, 2012.